Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Fund Letter | Southeastern Asset Management, Inc.Longleaf Partners Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long AVTR (Avantor) Life-sciences company Avantor detracted for the quarter. | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Christopher R. PaveseBroyhill Asset Management | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long AVTR (Avantor) Avantor was a close second. When we initiated... | BULL | View Pitch → | |
| Feb 20, 2026 | Fund Letter | Christopher R. PaveseBroyhill Asset Management | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Broyhill Asset Management 2025 Q4 (AVTR) Avantor was a close second. When we initiated... | BULL | View Pitch → | |
| Jan 20, 2026 | Fund Letter | Ross GlotzbachLongleaf Partners Global Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Longleaf Partners Global Fund 2025 Q4 (AVTR) We added a partial position of Avantor to the portfolio in the second half of the year after (and then while) the company had some self-inflicted ups and downs. It is probable... | BEAR | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.